Last reviewed · How we verify
NCT03970551: IOH
Lower Body Muscle Pre-activation in Initial Orthostatic Hypotension
NA trial testing Physical Counter-maneuver in Orthostatic Intolerance in 64 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | University of Calgary |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 64 |
| Start date | 1 July 2019 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Physical Counter-maneuver
- Stress Test
- Functional Electrical Stimulation
Conditions studied
- Orthostatic Intolerance — all drugs for Orthostatic Intolerance →
- Syncope — all drugs for Syncope →
- Fainting — all drugs for Fainting →
- Presyncope — all drugs for Presyncope →
Sponsor
University of Calgary
Who can join
Adults 18 to 50, any sex, with Orthostatic Intolerance or Syncope. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is aimed primarily at providing a simple and effective form of treatment to reduce the symptoms of Initial Orthostatic Hypotension (IOH) and prevent syncope. We will first characterize the physiology of IOH, and then we will study four sit-to-stand maneuvers, each with a different stress tests to identify the role of sympathetic activity vs. simple muscle contraction in IOH. Then we will complete an additional two sit-to-stands with interventions designed to decrease the blood pressure drop (and hopefully symptoms) with initial stand. These consist of physical counter maneuvers, which may be a possible treatment that can be used to mitigate the drop in blood pressure (BP) seen in IOH during a stand and relieve presyncope symptoms.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mitigating Initial Orthostatic Hypotension: Mechanistic Roles of Muscle Contraction Versus Sympathetic Activation.
Sheikh NA, Phillips AA, Ranada S, Lloyd M, et al · · 2022 · cited 11× · PMID 34990207 · DOI 10.1161/hypertensionaha.121.18580
Verify or expand the search:
- PubMed search for NCT03970551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Orthostatic Intolerance
Currently open trials in the same condition.
- NCT06939153 — Effects of Age, Sex and Isometric Exercise on Ventricular-Vascular Interactions During Cardiac Unloading · NA · recruiting
- NCT07195903 — The STAND-UP Study · NA · recruiting
- NCT05555771 — Paediatric Syncope in the Emergency Department · NA · recruiting
Other University of Calgary trials
Trials by the same sponsor.
- NCT06885996 — Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence · Phase 2 · not yet recruiting
- NCT05729503 — Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals · Phase 2 · not yet recruiting
- NCT07463339 — Microbiome-guided Prophylaxis to Reduce Ventilator-Associated Pneumonia in Intensive Care Units: A Pilot Randomized Cont · Phase 2 · not yet recruiting
- NCT07145645 — Topical Diclofenac vs.Oral Ibuprofen for MSK Pain in Children · Phase 3 · recruiting
- NCT07280325 — Moxie Self-Management and Education Support Program · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03970551 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Calgary
- Last refreshed: 29 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03970551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing